XML 37 R27.htm IDEA: XBRL DOCUMENT v3.22.2.2
Capital Stock and Equity Transactions (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 12 Months Ended
Aug. 13, 2021
Sep. 30, 2021
Sep. 30, 2022
Jun. 30, 2020
Jun. 30, 2022
Oct. 13, 2021
Common stock, shares authorized (in shares)   700,000,000 700,000,000   700,000,000  
Common stock, par value (in dollars per share)   $ 0.001 $ 0.001   $ 0.001  
Preferred stock, shares authorized (in shares)   10,000,000        
Derivative liability   $ 3,671,051        
Decrease in derivative liability       $ 2,930,289    
Common stock shares issued   698,375 94,615,023   93,316,288  
Unrealized gain       $ 922,314    
Increase in common shares $ 150,000,000          
Common stock on a fully diluted basis     $ 94,614   $ 93,315  
Vendor [Member]            
Common stock shares issued   290,000        
Fair market value   $ 22,300        
Fair market value of shares issued and expensed     29,500      
Issuance of common stock to vendors     600,000      
Employees [Member]            
Common stock shares issued   733,938        
Fair market value   $ 65,514        
Fair market value issued to employees     $ 40,135      
Issuance of common stock     698,735      
Preferred Stock Series A [Member]            
Preferred stock, shares authorized (in shares)     10,000,000   10,000,000  
Preferred stock, par value (in dollars per share)   $ 0.001 $ 0.001   $ 0.001 $ 0.001
Aggeregate shares of common stock     324,325      
Common stock shares issued upon conversion of preferred stock     125,014,495      
Percentage of the number of common outstanding share   55.00%        
Common stock on a fully diluted basis   $ 111,942,356        
Series B Preferred Stock [Member]            
Aggeregate shares of common stock     7,567      
Common stock shares issued upon conversion of preferred stock     1,120,064